Evaluation of Prognostic Nutritional Index in Patients Undergoing Radical Surgery with Nonsmall Cell Lung Cancer

REFERENCES

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al.: Global cancer statistics. CA Cancer J Clin 61(2), 69–90, 2011.
   PubMed Web of Science ®Google Scholar
• Coussens LM and Werb Z: Inflammation and cancer. Nature 420(6917), 860–867, 2002.
   PubMed Web of Science ®Google Scholar
• Lorusso G and Ruegg C: The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 130, 1091–1103, 2008.
   PubMed Web of Science ®Google Scholar
• Doweiko JP and Nompleggi DJ: The role of albumin in human physiology and pathophysiology, Part III: Albumin and disease states. J Parenter Enteral Nutr 15, 476–483, 1991.
   PubMed Web of Science ®Google Scholar
• Lien YC, Hsieh CC, Wu YC, Hsu HS, Hsu WH, et al.: Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastrointest Surg 8, 1041–1048, 2004.
   PubMed Web of Science ®Google Scholar
• Uppal S, Al-Niaimi A, Rice LW, Rose SL, Kushner DM, et al.: Preoperative hypoalbuminemia is an independent predictor of poor perioperative outcomes in women undergoing open surgery for gynecologic malignancies. Gynecol Oncol 131, 416–422, 2013.
   PubMed Web of Science ®Google Scholar
• Don BR and Kaysen G: Poor nutritional status and inflammation: serum albumin: relationship to inflammation and nutrition. Seminars in Dialysis 17, 432–437, 2004.
   PubMed Web of Science ®Google Scholar
• Phillips A, Shaper AG, and Whincup PH: Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 2(8677), 1434–1436, 1989.
   PubMed Web of Science ®Google Scholar
• Nozoe T, Ninomiya M, Maeda T, Matsukuma A, Nakashima H, et al.: Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg Today 40, 440–443, 2010.
   PubMed Web of Science ®Google Scholar
• Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, et al.: Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg 98, 268–274, 2011.
   PubMed Web of Science ®Google Scholar
• Nozoe T, Kohno M, Iguchi T, Mori E, Maeda T, et al.: The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma. Surg Today 42, 532–535, 2012.
   PubMed Web of Science ®Google Scholar
• Feng JF and Chen QX: Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma. Ther Clin Risk Manag 10, 1–7, 2014.
   PubMed Web of Science ®Google Scholar
• Onodera T, Goseki N, and Kosaki G: [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi 85, 1001–1005, 1984.
   PubMedGoogle Scholar
• Sobin LH GM and Wittekind C: TNM Classification of Malignant Tumours, 7th Ed. New York: Wiley, 2009.
   Google Scholar
• Ettinger D, Bepler G, Bueno R, Chang A, Chang J, et al.: Non-small cell lung cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network: JNCCN 4, 548, 2006.
   PubMedGoogle Scholar
• Crowley J, LeBlanc M, Jacobson J, and Salmon SE: Some Exploratory Tools for Survival Analysis. New York: Springer, 1997.
   Google Scholar
• Garces YI, Yang P, Parkinson J, Zhao X, Wampfler JA, Ebbert JO, Sloan JA: The relationship between cigarette smoking and quality of life after lung cancer diagnosis. CHEST Journal 126, 1733–1741, 2004.
   PubMed Web of Science ®Google Scholar
• Goseki N, Okamoto A, and Onodera T: [Postoperative nutritional assessment in gastric and colorectal cancer]. Nihon Geka Gakkai Zasshi 87, 853–858, 1986.
   PubMedGoogle Scholar
• Mullen JL, Buzby GP, Matthews DC, Smale BF, Rosato EF: Reduction of operative morbidity and mortality by combined preoperative and postoperative nutritional support. Ann Surg 192, 604–613, 1980.
   PubMed Web of Science ®Google Scholar
• Smith RC and Hartemink R: Improvement of nutritional measures during preoperative parenteral nutrition in patients selected by the prognostic nutritional index: a randomized controlled trial. J Parenter Enteral Nutr 12, 587–591, 1988.
   PubMed Web of Science ®Google Scholar
• Nitenberg G and Raynard B: Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 34(3), 137–168, 2000.
   PubMed Web of Science ®Google Scholar
• Paccagnella A, Morassutti I, and Rosti G: Nutritional intervention for improving treatment tolerance in cancer patients. Curr Opin Oncol 23, 322–330, 2011.
   PubMed Web of Science ®Google Scholar
• Patel AM, Davila DG, and Peters SG: Paraneoplastic syndromes associated with lung cancer. Mayo Clin Proc 68, 278–287, 1993.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Arends J: The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9(Suppl. 2), S51–S63, 2005.
   PubMedGoogle Scholar
• Okuyama T, Tanaka K, Akechi T, Kugaya A, Okamura H, et al.: Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening. J Pain Symptom Manage 22, 554–564, 2001.
   PubMed Web of Science ®Google Scholar
• Coats AJ: Origin of symptoms in patients with cachexia with special reference to weakness and shortness of breath. Int J Cardiol 85(1), 133–139, 2002.
   PubMed Web of Science ®Google Scholar
• Fuhrman MP, Charney P, and Mueller CM: Hepatic proteins and nutrition assessment. J Am Diet Assoc 104, 1258–1264, 2004,.
   PubMed Web of Science ®Google Scholar
• Chandrasinghe PC, Ediriweera DS, Kumarage SK, and Deen KI: Pre-operative hypoalbuminaemia predicts poor overall survival in rectal cancer: a retrospective cohort analysis. BMC Clin Pathol 13, 12, 2013.
   PubMedGoogle Scholar
• Ionescu D, Tibrea C, and Puia C: Pre-operative hypoalbuminemia in colorectal cancer patients undergoing elective surgery: a major risk factor for postoperative outcome. Chirurgia (Bucur) 108, 822–828, 2013.
   PubMed Web of Science ®Google Scholar
• Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357, 539–545, 2001.
   PubMed Web of Science ®Google Scholar
• Kundu JK and Surh YJ: Inflammation: gearing the journey to cancer. Mutat Res 659, 15–30, 2008.
   PubMed Web of Science ®Google Scholar
• de Visser KE and Coussens LM: The interplay between innate and adaptive immunity regulates cancer development. Cancer Immunol Immunother 54, 1143–1152, 2005.
   PubMed Web of Science ®Google Scholar
• Balmanoukian A, Ye X, Herman J, Laheru D, Grossman SA: The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas. Cancer Invest 30, 571–576, 2012.
   PubMed Web of Science ®Google Scholar
• Fogar P, Sperti C, Basso D, Sanzari MC, Greco E, et al.: Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas 32, 22–28, 2006.
   PubMed Web of Science ®Google Scholar
• Roxburgh CS and McMillan DC: Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6, 149–163, 2010.
   PubMed Web of Science ®Google Scholar
• Migita K, Takayama T, Saeki K, Matsumoto S, Wakatsuki K, et al.: The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol 20, 2647–2654, 2013.
   PubMed Web of Science ®Google Scholar
• Chandra RK: Nutrition and the immune system: an introduction. Am J Clin Nutr 66, 460S–463S, 1997.
   PubMed Web of Science ®Google Scholar
• Pagès F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, et al.: In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. Journal of Clinical Oncology 27, 5944–5951, 2009.
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Usui S, Kikuchi S, Goto Y, Sakai M, e al.: Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer 75, 223–227, 2012.
   PubMed Web of Science ®Google Scholar
• DeNardo DG, Andreu P, and Coussens LM: Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer and Metastasis Reviews 29, 309–316, 2010.
   PubMed Web of Science ®Google Scholar
• Robinson SC and Coussens LM: Soluble mediators of inflammation during tumor development. Advances in Cancer Research 93, 159–187, 2005.
   PubMed Web of Science ®Google Scholar
• Smyth MJ, Dunn GP, and Schreiber RD: Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 90, 1–50, 2006.
   PubMed Web of Science ®Google Scholar
• Karin M and Greten FR: NF-κB: linking inflammation and immunity to cancer development and progression. Nature Reviews Immunology, 5, 749–759, 2005.
   PubMed Web of Science ®Google Scholar
• Kelsey CR, Marks LB, Hollis D, Hubbs JL, Ready NE, et al.: Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer 115, 5218–5227, 2009.
   PubMed Web of Science ®Google Scholar
• Arriagada R, Dunant A, Pignon JP, Bergman B, Chabowski M, Grunenwald D, Kozlowski M, Le Pechoux C, Pirker R, Pinel MI, et al.: Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer. J Clin Oncol 28(1), 35–42, 2010.
   PubMed Web of Science ®Google Scholar
• Altman DG, Lausen B, Sauerbrei W, and Schumacher M: Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86, 829–835, 1994.
   PubMed Web of Science ®Google Scholar